InvestorsHub Logo
Followers 2
Posts 1274
Boards Moderated 0
Alias Born 08/09/2013

Re: None

Sunday, 08/02/2020 3:46:12 PM

Sunday, August 02, 2020 3:46:12 PM

Post# of 7787
https://ec.europa.eu/health/documents/community-register/2020/20200727148693/dec_148693_en.pdf

relating to the designation of "Imetelstat sodium" as an orphan medicinal product under
Regulation (EC) No 141/2000 of the European Parliament and of the Council

Article 1
The medicinal product “Imetelstat sodium” is designated as an orphan medicinal product for
the indication: Treatment of myelodysplastic syndromes. It shall be entered in the
Community Register of Orphan Medicinal Products under number EU/3/20/2305.
Article 2
The European Medicines Agency shall make available to all interested parties the opinion of
the Committee on Orphan Medicinal Products referred to in this Decision.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News